期刊文献+

免疫调节性寡聚脱氧核苷酸筛选方法的建立、优化和应用 被引量:2

Establishment,optimization and application of a screening method for immunoregulatory oligodeoxynucleotides
下载PDF
导出
摘要 目的:建立一套合理而便捷的实验体系,为开发新型免疫调节性寡聚脱氧核苷酸(ODN)提供筛选方法。方法:利用含有CpG基序的免疫刺激性寡聚脱氧核苷酸(CpG ODN)作为刺激物,将人外周血单个核细胞(PBMC)作为研究对象,分别以细胞的增殖程度和刺激上清的抗病毒活性作为检测指标,优化各项实验条件,综合评定寡聚脱氧核苷酸的免疫调节活性。结果:成功建立了由阳性免疫调节性ODNA151抑制CpG ODN诱导的人PBMC增殖及抗病毒活性的筛选方法。结论:免疫调节性ODN筛选方法的成功建立,为下一步研究开发新型免疫调节性ODN奠定了基础。 AIM: To establish a set of reasonable and convenient experimental system to provide a screening method for the development of novel immunoregulatory oligodeoxynucleotides. METHODS: The human PBMCs were stimulated by CpG ODN and/or immunoregulatory ODN. The cell proliferation and anti-viral activity of the supernatant induced by CpG ODN were examined by thymidine incorporation and anti-viral bioassay to evaluate the immunoregulatory activity of candidate ODN. The experimental conditions were also optimized. RESULTS: A screening method on which A151, a positive immunoregulatory ODN, inhibited the proliferation and anti-viral activity of the CpG ODN-induced human PBMCs was successfully established. CONCLUSION: The successful establishment of CpG ODN based screening method lays the foundations for further development of novel immunoregulatory oligodeoxynucleotides.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2007年第11期1017-1020,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金海外杰出青年基金资助(30328010)
关键词 免疫调节 寡聚脱氧核苷酸 CPG ODN 人外周血单个核细胞 immunological regulation oligodeoxynucleoti-de CpG ODN human PBMC
  • 相关文献

参考文献9

  • 1Wagner H.Bacterial CpG DNA activates immune cells to signal infectious danger[J].Adv Immunol,1999,73:329-368.
  • 2Klinman DM.Immunotherapeutic uses of CpG oligodeoxynucleotides[J].Nat Rev Immunol,2004,4 (4):249-258.
  • 3Halpern MD,Pisetsky DS.In vitro inhibition of murine IFN-γ production by phosphorothioate deoxyguanosine oligomers[J].Immunopharmacology,1995,29(1):47 -52.
  • 4Shirota H,Gursel I,Gursel M,et al.Suppressive oligodeoxynucleotides protect mice from lethal endotoxic shock[J].J Immunol,2005,174(8):4579 -4583.
  • 5Ho PP,Fontoura P,Ruiz PJ,et al.An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems[J].J Immunol,2003,171 (9):4920 -4926.
  • 6Dong L,Ito S,Ishii KJ,et al.Suppressive oligonucleotides protect against collagen-induced arthritis in mice[J].Arthritis Rheum,2004,50(5):1686-1689.
  • 7Barrat FJ,Meeker T,Gregorio J,et al.Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus[J].J Exp Med,2005,202(8):1131 -1139.
  • 8Gursel I,Gursel M,Yamada H,et al.Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation[J].J Immunol,2003,171(3):1393-1400.
  • 9Bao M,Zhang Y,Wan M,et al.Anti-SARS-CoV immunity induced by a novel CpG oligodeoxynucleotide[J].Clin Immunol,2006,118(2 -3):180-187.

同被引文献5

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部